Share this link via:
Add Citation
Global Industry Hub. (Sep, 2024). Cell-based Assays Market Share & Forecast, 2024 - 2030 Global Industry Hub. Retrieved
Report ID: GIH 1040 | Sep 2024 | Format:
Request CustomizationShare this link via:
Add Citation
Global Industry Hub. (Sep, 2024). Cell-based Assays Market Share & Forecast, 2024 - 2030 Global Industry Hub. Retrieved
Cell-based Assays Market size was valued at US$ 18.8 Bn in 2024, registering a CAGR of 8.9% during the forecast period (2024-2030), and the market is projected to be worth US$ 33.9 Bn by 2030.
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Market Updates, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprint by Global Industry Hub.
Cell-based Assays Market Scope:
The Cell-based Assays market is divided based on product, end user, application, and region. Each category has various sub-segments, and current trends in each segment help producers target specific customers effectively.
Important Features of the Report:
Reasons for buying this report:
Products & Services Outlook
Reagents
Assay Kits
Cell Growth Assays
Reporter Gene Assays
Cell Death Assays
Second Messenger Assays
Microplates
Probes & Labels
Instruments & Software
Cell Lines
Primary Cell Lines
Stem Cell Lines
Immortalized Cell Lines
Application Outlook
Basic Research
Drug Discovery
Other Applications
End Use Outlook
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations (CROs)
Regional Outlook
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Key players in the industry are adopting growth strategies like partnerships, collaborations, mergers and acquisitions, and awareness programs to strengthen their market presence. The report also lists industry players for end users, facilitating communication between manufacturers and consumers.
In April 2024, BD India launched the BD Vacutainer UltraTouch Push Button Blood Collection Set to minimize patient pain and discomfort. The device featured BD RightGauge and PentaPoint technologies, reducing insertion pain and needle injury risks.
In March 2024, Lonza acquired the Genentech manufacturing facility in Vacaville, U.S., from F. Hoffmann-La Roche Ltd. (Roche Holdings AG) through an agreement. The acquisition augmented Lonza's large-scale biologics manufacturing capacity, making it one of the largest biologics manufacturing facilities globally.
Updated Version & Immediate Delivery Available
You'll get the sample you asked for by email. Remember to check your spam folder as well. If you have any further questions or require additional assistance, feel free to let us know via-
03 Sep 2024 This Report Contains the Latest Market Numbers, Statistics & Data Aavailable